Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

Gene Ther. 2018 Sep;25(6):450. doi: 10.1038/s41434-018-0031-x.

Authors

A Georgiadis¹, Y Duran¹, J Ribeiro¹, L Abelleira-Hervas¹, S J Robbie¹, B Sünkel-Laing¹, S Fourali¹, A Gonzalez-Cordero¹, E Cristante¹, M Michaelides^{1

2}, J W B Bainbridge^{1

2}, A J Smith¹, R R Ali^{3

4}

Affiliations

¹ Department of Genetics, UCL Institute of Ophthalmology, London, EC1V 9EL, UK.
² NIHR Biomedical Research Centre at Moorfields Eye Hospital, London, EC1V 2PD, UK.
³ Department of Genetics, UCL Institute of Ophthalmology, London, EC1V 9EL, UK. r.ali@ucl.ac.uk.
⁴ NIHR Biomedical Research Centre at Moorfields Eye Hospital, London, EC1V 2PD, UK. r.ali@ucl.ac.uk.

Abstract

The authors originally published this article under the incorrect license type; this has now been corrected and is published under the CC-BY license.

Publication types

Published Erratum

Grants and funding